Sona Nanotech Inc (TSE:SONA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sona Nanotech Inc. is showcasing its Targeted Hyperthermia Therapy (THT) cancer treatment at the NCL’s 20th anniversary symposium, celebrating advances in cancer nanotechnology. The company has successfully completed initial safety studies for its gold nanorods, paving the way for further human trials in 2025.
For further insights into TSE:SONA stock, check out TipRanks’ Stock Analysis page.
